跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Biolipy - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Biolipy
Approved
STANDARD
Biolipy
Nabros Pharma Pvt. Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
030b82eee5d5aecd
Company
Nabros Pharma Pvt. Ltd.
Type
Standard
Approval Details
Approval Id
030b82eee5d5aecd
Drug Approval Philippines Name
Biolipy
Product Name
Biolipy
Registration Number
DRP-5608-15
Brand Name
Biolipy
Generic Name
Phospholipids + Multivitamins
Dosage Form
Capsule
Dosage Strength
300 mg/6 mg/6 mg/6 mg/30 mg/6 mg/6 mg
Manufacturer
Nabros Pharma Pvt. Ltd.
Importer
Ambica International Corporation
Distributor
228 Pharma Trading
Issuance Date
27 March 2024
Expiry Date
13 October 2029
Pharmacologic Category
Liver Therapy
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
030b82eee5d5aecd
Type
Standard
Back to Philippines FDA Approvals